Applicability of digital analysis and imaging technology in neuropathology assessment

Neuropathology

Volumn 36, Issue 3, 2016, Pages 270-282

  Dunn, William D ^a   Gearing, Marla ^a   Park, Yuna ^a   Zhang, Lifan ^a   Hanfelt, John ^b   Glass, Jonathan D ^a   Gutman, David A ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

Alzheimer's disease; Braak; CERAD; Digital analysis; Neuropathology

Indexed keywords

AMYLOID BETA PROTEIN;

ADULT; ALGORITHM; ALZHEIMER DISEASE; ARTICLE; BRAIN REGION; CORRELATION ANALYSIS; COST; DIGITAL IMAGING; DISEASE SEVERITY ASSESSMENT; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; MALE; MIDDLE AGED; NEUROPATHOLOGY; PILOT STUDY; PRIORITY JOURNAL; SCORING SYSTEM; VALIDATION STUDY; AGED; BRAIN; COMPUTER ASSISTED DIAGNOSIS; DIAGNOSTIC IMAGING; IMAGE ENHANCEMENT; METABOLISM; PROCEDURES; REPRODUCIBILITY;

AGED; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; BRAIN; DIAGNOSIS, COMPUTER-ASSISTED; FEMALE; HUMANS; IMAGE ENHANCEMENT; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS;

EID: 84947203893     PISSN: 09196544     EISSN: 14401789     Source Type: Journal    
DOI: 10.1111/neup.12273     Document Type: Article

References (32)

1. Perl DP. Neuropathology of Alzheimer's disease. Mt Sinai J Med 2010; 77 (1): 32-42.
2. Miao J, Xu F, Davis J, Otte-Höller I, Verbeek MM, Van Nostrand WE. Cerebral microvascular amyloid beta protein deposition induces vascular degeneration and neuroinflammation in transgenic mice expressing human vasculotropic mutant amyloid beta precursor protein. Am J Pathol 2005; 167 (2): 505-515.
3. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991; 82 (4): 239-259.
4. Mirra SS, Heyman A, McKeel D et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991; 41 (4): 479-486.
5. Thal DR, Rüb U, Orantes M, Braak H. Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology 2002; 58 (12): 1791-1800.
6. Hyman BT, Phelps CH, Beach TG et al. National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease. Alzheimers Dement 2012; 8 (1): 1-13.
7. Montine TJ, Phelps CH, Beach TG et al. National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach. Acta Neuropathol 2012; 123 (1): 1-11.
8. Chui HC, Tierney M, Zarow C, Lewis A, Sobel E, Perlmutter LS. Neuropathologic diagnosis of Alzheimer disease: interrater reliability in the assessment of senile plaques and neurofibrillary tangles. Alzheimer Dis Assoc Disord 1993; 7 (1): 48-54.
9. Halliday G, Ng T, Rodriguez M et al. Consensus neuropathological diagnosis of common dementia syndromes: testing and standardising the use of multiple diagnostic criteria. Acta Neuropathol 2002; 104 (1): 72-78.
10. Nelson PT, Kukull WA, Frosch MP. Thinking outside the box: Alzheimer-type neuropathology that does not map directly onto current consensus recommendations. J Neuropathol Exp Neurol 2010; 69 (5): 449-454.
11. Beach TG, Monsell SE, Phillips LE, Kukull W. Accuracy of the clinical diagnosis of Alzheimer disease at National Institute on Aging Alzheimer Disease Centers, 2005-2010. J Neuropathol Exp Neurol 2012; 71 (4): 266-273.
12. Walker L, McAleese KE, Thomas AJ et al. Neuropathologically mixed Alzheimer's and Lewy body disease: burden of pathological protein aggregates differs between clinical phenotypes. Acta Neuropathol 2015; 129 (5): 729-748.
13. Neltner JH, Abner EL, Schmitt FA et al. Digital pathology and image analysis for robust high-throughput quantitative assessment of Alzheimer disease neuropathologic changes. J Neuropathol Exp Neurol 2012; 71 (12): 1075-1085.
14. Cantaloni C, Tonini RE, Eccher C et al. Diagnostic value of automated Her2 evaluation in breast cancer: a study on 272 equivocal (score 2+) Her2 immunoreactive cases using an FDA approved system. Appl Immunohistochem Mol Morphol 2011; 19 (4): 306-312.
15. Nagy Z, Yilmazer-Hanke DM, Braak H, Braak E, Schultz C, Hanke J. Assessment of the pathological stages of Alzheimer's disease in thin paraffin sections: a comparative study. Dement Geriatr Cogn Disord 1998; 9 (3): 140-144.
16. Chandana R, Mythri RB, Mahadevan A, Shankar SK, Srinivas Bharath MM. Biochemical analysis of protein stability in human brain collected at different post-mortem intervals. Indian J Med Res 2009; 129 (2): 189-199.
17. Harrison PJ. Advances in post mortem molecular neurochemistry and neuropathology: examples from schizophrenia research. Br Med Bull 1996; 52 (3): 527-538.
18. Webster JD, Miller MA, Dusold D, Ramos-Vara J. Effects of prolonged formalin fixation on diagnostic immunohistochemistry in domestic animals. J Histochem Cytochem 2009; 57 (8): 753-761.
19. Pikkarainen M, Martikainen P, Alafuzoff I. The effect of prolonged fixation time on immunohistochemical staining of common neurodegenerative disease markers. J Neuropathol Exp Neurol 2010; 69 (1): 40-52.
20. Albert MS, DeKosky ST, Dickson D et al. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011; 7 (3): 270-279.
21. Cooper LA, Kong J, Gutman DA, Dunn WD, Nalisnik M, Brat DJ. Novel genotype-phenotype associations in human cancers enabled by advanced molecular platforms and computational analysis of whole slide images. Lab Invest [Internet] 2015 Jan 19. Available from URL: doi: 10.1038/labinvest.2014.153.
22. Kothari S, Phan JH, Stokes TH, Wang MD. Pathology imaging informatics for quantitative analysis of whole-slide images. J Am Med Inform Assoc 2013; 20 (6): 1099-1108.
23. Berg L, McKeel DW Jr, Miller JP et al. Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype. Arch Neurol 1998; 55 (3): 326-335.
24. Markesbery WR, Schmitt FA, Kryscio RJ, Davis DG, Smith CD, Wekstein DR. Neuropathologic substrate of mild cognitive impairment. Arch Neurol 2006; 63 (1): 38-46.
25. Sonnen JA, Larson EB, Crane PK et al. Pathological correlates of dementia in a longitudinal, population-based sample of aging. Ann Neurol 2007; 62 (4): 406-413.
26. Bancher C, Jellinger K, Lassmann H, Fischer P, Leblhuber F. Correlations between mental state and quantitative neuropathology in the Vienna Longitudinal Study on Dementia. Eur Arch Psychiatry Clin Neurosci 1996; 246 (3): 137-146.
27. Nelson PT, Jicha GA, Schmitt FA et al. Clinicopathologic correlations in a large Alzheimer disease center autopsy cohort: neuritic plaques and neurofibrillary tangles "do count" when staging disease severity. J Neuropathol Exp Neurol 2007; 66 (12): 1136-1146.
28. Isaacs M, Lennerz JK, Yates S, Clermont W, Rossi J, Pfeifer JD. Implementation of whole slide imaging in surgical pathology: A value added approach. J Pathol Inform 2011; 2: 39.
29. Liu JYW, Ellis M, Brooke-Ball H et al. High-throughput, automated quantification of white matter neurons in mild malformation of cortical development in epilepsy. Acta Neuropathol Commun 2014; 2: 72.
30. Pantanowitz L, Valenstein PN, Evans AJ et al. Review of the current state of whole slide imaging in pathology. J Pathol Inform 2011; 2: 36.
31. Webster JD, Dunstan RW. Whole-slide imaging and automated image analysis: considerations and opportunities in the practice of pathology. Vet Pathol 2014; 51 (1): 211-223.
32. Ho J, Ahlers SM, Stratman C et al. Can digital pathology result in cost savings? A financial projection for digital pathology implementation at a large integrated health care organization. J Pathol Inform 2014; 5: 33.